Uttarakhand government cancels license of 14 products of Patanjali

The Uttarakhand government has told the Supreme Court in an affidavit that it has given permission to file a complaint against Baba Ramdev's Divya Pharmacy and Patanjali Ayurved Ltd for repeated violations of the drug advertising law and suspended the manufacturing licenses of 14 of their products. In the affidavit, the Uttarakhand government submitted that its state licensing authority has issued a public notice stating that publication of advertisements contrary to law will attract strict disciplinary and legal action, including fine, imprisonment or both.

The affidavit filed by the State Licensing Authority, Ayurvedic and Unani Services, said it sought permission on April 12 from the Drug Inspector, Haridwar, to file a complaint against Divya Pharmacy and Patanjali Ayurveda Ltd for repeated violations of the Drugs and Magic Remedies Act.

It said, “The SLA issued an order dated April 15, 2024 to Divya Pharmacy and respondent No. 5-Patanjali Ayurveda Limited, directing them to stop the sale of 14 of their products, namely, ‘Swasari Gold’, ‘Swasari Vati, Bronkom’ Manufacturing License for ', 'Swasari Pravahi', 'Swasari Awaleh', 'Muktavati Extra Power', 'Lipidome', 'BP Grit', 'Madhugrit', 'Madhunashinivati Extra Power', 'Livamrit Advance', 'Livogrit', 'Eyegrit Gold' and 'Patanjali Drishti Eye Drop' are suspended with immediate effect under Rule 159(1) of the Drugs and Cosmetics Rules, 1945.

The affidavit further states, “District Ayurvedic and Unani Officer, Haridwar filed an FIR under Section 3 of the Drugs and Magic Remedies (Objectionable Advertisements) Act 195 against Swami Ramdev, Acharya Balkrishna, Divya Pharmacy and Patanjali Ayurveda Limited before the Chief Judicial Magistrate, Haridwar. Filed a criminal complaint under sections 4 and 7."

The SLA said it will continue to take all appropriate steps against Divya Pharmacy and Patanjali Ayurved Limited as per the procedure laid down in law and the directions issued by the Supreme Court. In an order passed on April 10, the apex court ordered the then Joint Director of the State Licensing Authority and all the officers holding the post of District Ayurvedic and Unani Officer, Haridwar from 2018 till date to file their respective affidavits and explain their inaction Was.

The Indian Medical Association has sought action against Patanjali for violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, which prohibits advertising of certain products to treat specific diseases and disorders, including diabetes, heart disease, high or low blood pressure. Prevents.